ArticleCancers2021

Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib.

Piero Colombatto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.